Pre-operative haematological assessment in patients scheduled for major surgery

Anaesthesia

Volumn 71, Issue , 2016, Pages 19-28

  Munoz M ^a   Gomez Ramirez S ^b   Kozek Langeneker, S ^c  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b Xanit International Hospital   (Spain)

^c Evangelical Hospital   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; IRON;

ANEMIA; BLOOD CLOTTING PARAMETERS; ERYTHROPOIESIS; HEMATOLOGICAL PROCEDURE; HEMOSTASIS; HUMAN; IRON THERAPY; MAJOR SURGERY; PATIENT ASSESSMENT; PREOPERATIVE PERIOD; REVIEW; THROMBOCYTE FUNCTION; BLOOD COAGULATION DISORDERS; BLOOD LOSS, SURGICAL; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROCEDURES;

ANEMIA; BLOOD COAGULATION DISORDERS; BLOOD LOSS, SURGICAL; HUMANS; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE;

EID: 84952334147     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.13304     Document Type: Review

References (85)

1. Norgaard A, De Lichtenberg TH, Nielsen J, Johansson PI,. Monitoring compliance with transfusion guidelines in hospital departments by electronic data capture. Blood Transfusion 2014; 12: 509-19.
2. Roubinian NH, Escobar GJ, Liu V, et al., Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. Transfusion 2014; 54: 2678-86.
3. Gombotz H, Rehak PH, Shander A, Hofmann A,. The second Austrian benchmark study for blood use in elective surgery: results and practice change. Transfusion 2014; 54: 2646-57.
4. Shander A, Van Aken H, Colomina MJ, et al., Patient blood management in Europe. British Journal of Anaesthesia 2012; 109: 55-68.
5. World Health Assembly. WHA 63.12 (resolution). Availability, safety and quality of blood products. 2010. http://apps.who.int/gb/ebwha/pdf-files/WHA63/A63-R12-en.pdf (accessed 24/07/2015).
6. Jaeschke R, Guyatt GH, Dellinger P, et al., Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. British Medical Journal 2008; 337: a744.
7. Beris P, Muñoz M, García-Erce JA, Thomas D, Maniatis A, Van der Linden P,. Perioperative anaemia management: consensus statement on the role of intravenous iron. British Journal of Anaesthesia 2008; 100: 599-604.
8. Goodnough LT, Maniatis A, Earnshaw P, et al., Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. British Journal of Anaesthesia 2011; 106: 13-22.
9. Carson JL, Grossman BJ, Kleinman S, et al., Red blood cell transfusion: a clinical practice guideline from the AABB. Annals of Internal Medicine 2012; 157: 49-58.
10. Leal-Noval SR, Muñoz M, Asuero M, et al., Spanish consensus statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document". Blood Transfusion 2013; 11: 585-610.
11. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al., Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. European Journal of Anaesthesiology 2013; 30: 270-382.
12. Muñoz M, Gómez-Ramírez S, Kozek-Langeneker S, et al., 'Fit to fly': overcoming the barriers to preoperative haemoglobin optimization in surgical patients. British Journal of Anaesthesia 2015; 115: 152-224.
13. Wu WC, Schifftner TL, Henderson WG, et al., Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. Journal of the American Medical Association 2007; 297: 2481-8.
14. Beattie WS, Karkouti K, Wijeysundera DN, Tait G,. Risk associated with preoperative anemia in noncardiac surgery: a single-center cohort study. Anesthesiology 2009; 110: 574-81.
15. Musallam KM, Tamim HM, Richards T, et al., Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 2011; 378: 1396-407.
16. Muñoz M, Garcia-Erce JA, Remacha AF,. Disorders of iron metabolism. Part II: iron deficiency and iron overload. Journal of Clinical Pathology 2011; 64: 287-96.
17. Thomas DW, Hinchliffe RF, Briggs C, Macdougall IC, Littlewood T, Cavill I,; British Committee for Standards in Haematology. Guideline for the laboratory diagnosis of functional iron deficiency. British Journal of Haematology 2013; 161: 639-48.
18. Muñoz M, Gómez-Ramírez S, Martín-Montañez E, Auerbach M,. Perioperative anemia management in colorectal cancer patients: a pragmatic approach. World Journal of Gastroenterology 2014; 20: 1972-85.
19. Cuenca J, García-Erce JA, Martínez F, Cardona R, Pérez-Serrano L, Muñoz M,. Pre-operative haematinics and transfusion protocol reduce the need for transfusion after total knee replacement. International Journal of Surgery 2007; 5: 89-94.
20. Rogers BA, Cowie A, Alcock C, Rosson JW,. Identification and treatment of anaemia in patients awaiting hip replacement. Annals of the Royal College of Surgeons of England 2008; 90: 504-7.
21. Okuyama M, Ikeda K, Shibata T, Tsukahara Y, Kitada M, Shimano T,. Preoperative iron supplementation and intra-operative transfusion during colorectal cancer surgery. Surgery Today 2005; 35: 36-40.
22. Quinn M, Drummond RJ, Ross F, Murray J, Murphy J, MacDonald A,. Short course pre-operative ferrous sulphate supplementation-is it worthwhile in patients with colorectal cancer? Annals of the Royal College of Surgeons of England 2010; 92: 569-72.
23. Lachance K, Savoie M, Bernard M, et al., Oral ferrous sulfate does not increase preoperative hemoglobin in patients scheduled for hip or knee arthroplasty. Annals of Pharmacotherapy 2011; 45: 764-70.
24. Crosby L, Palarski VA, Cottington E, Cmolik B,. Iron supplementation for acute blood loss anemia after coronary artery bypass surgery: a randomized, placebo-controlled study. Heart and Lung 1994; 23: 493-9.
25. Sutton PM, Cresswell T, Livesey JP, Speed K, Bagga T,. Treatment of anaemia after joint replacement. Journal of Bone and Joint Surgery. British Volume 2004; 86: 31-3.
26. Mundy GM, Birtwistle SJ, Power RA,. The effect of iron supplementation on the level of haemoglobin after lower limb arthroplasty. Journal of Bone and Joint Surgery. British Volume 2005; 87: 213-7.
27. Parker MJ,. Iron supplementation for anemia after hip fracture surgery: a randomized trial of 300 patients. Journal of Bone and Joint Surgery. American Volume 2010; 92: 265-9.
28. Díez-Lobo AI, Fisac-Martín MP, Bermejo-Aycar I, Muñoz M,. Preoperative intravenous iron administration corrects anemia and reduces transfusion requirement in women undergoing abdominal hysterectomy. Transfusion Alternatives in Transfusion Medicine 2007; 9: 114-9.
29. Bisbe E, García-Erce JA, Díez-Lobo AI, Muñoz M,; Anaemia Working Group España. A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery. British Journal of Anaesthesia 2011; 107: 477-8.
30. Díaz Espallardo C, Laso Morales MJ, Colilles Calvet C, Mora López L, Roig Martínez I, Martínez Marín MT,. [ The multidisciplinary approach is useful for optimising preoperative haemoglobin in colorectal cancer surgery ]. Cirugía Española 2011; 89: 392-9.
31. Basora M, Colomina MJ, Tio M, Mora L, Salazar F, Ciercoles E,. Optimizing preoperative haemoglobin with intravenous iron. British Journal of Anaesthesia 2013; 110: 488-90.
32. Yoo YC, Shim KK, Kim JC, Jo YY, Lee JH, Kwak YL,. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology 2011; 115: 929-37.
33. Serrano-Trenas JA, Ugalde PF, Cabello LM, Chofles LC, Lázaro PS, Benítez PC,. Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial. Transfusion 2011; 51: 97-104.
34. Muñoz M, Gómez-Ramírez S, Cuenca J, García-Erce JA, Iglesias-Aparicio D, Haman-Alcober S, et al., Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion 2014; 54: 289-99.
35. Muñoz M, Gómez-Ramírez S, Martín-Montañez A, Naveira E, Seara J, Pavía J,. Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study. Blood Transfusion 2014; 12: 40-9.
36. Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM,. Intravenous iron following cardiac surgery does not increase the infection rate. Surgical Infections 2006; 7: 361-6.
37. European Medicines Agency. New recommendations to manage risk of allergic reactions with intravenous iron-containing medicines. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news-and-events/news/2013/06/newsdetail-001833.jsp&mid=WC0b01ac058004d5c1 (accessed 24/07/2015).
38. Rampton D, Folkersen J, Fishbane S, et al., Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management. Haematologica 2014; 99: 1671-6.
39. Avni T, Bieber A, Grossman A, Green H, Leibovici L, Gafter-Gvili A,. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clinic Proceedings 2015; 90: 12-23.
40. Reinisch W, Staun M, Bhandari S, Muñoz M,. State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. Journal of Crohn's and Colitis 2013; 7: 429-40.
41. Calvet X, Ruíz MÀ, Dosal A, et al., Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose for the ambulatory treatment of severe iron deficiency. PLoS ONE 2012; 7: e45604.
42. Lin DM, Lin ES, Tran MH,. Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfusion Medicine Review 2013; 27: 221-34.
43. Weber EWG, Slappendel R, Hémon Y, et al., Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST). European Journal of Anaesthesiology 2005; 22: 249-57.
44. Karkouti K, McCluskey SA, Evans L, Mahomed N, Ghannam M, Davey R,. Erythropoietin is an effective clinical modality for reducing RBC transfusion in joint surgery. Canadian Journal of Anesthesia 2005; 52: 363-8.
45. Rosencher N, Poisson D, Albi A, Aperce M, Barré J, Samama CM,. Two injections of erythropoietin correct moderate anemia in most patients awaiting orthopedic surgery. Canadian Journal of Anesthesia 2005; 52: 160-5.
46. Alghamdi AA, Albanna MJ, Guru V, Brister SJ,. Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transfusion in cardiac surgery? A systematic review and meta-analysis. Journal of Cardiac Surgery 2006; 21: 320-6.
47. Cladellas M, Farré N, Comín-Colet J, et al., Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement. American Journal of Cardiology 2012; 110: 1021-6.
48. Weltert L, Rondinelli B, Bello R, et al., A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial. Transfusion 2015; 55: 1644-54.
49. Devon KM, McLeod RS,. Pre and peri-operative erythropoietin for reducing allogeneic blood transfusions in colorectal cancer surgery. Cochrane Database of Systematic Reviews 2009; 1: CD007148.
50. Muñoz M, Leal-Noval SR, García-Erce JA,. [ Is there still a role for recombinant erythropoietin in the management of anaemia of critical illness? ]. Medicina Clínica 2009; 132: 749-55.
51. Locatelli F, Bárány P, Covic A, et al.,; ERA-EDTA ERBP Advisory Board. Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement. Nephrology, Dialysis, Transplantation 2013; 28: 1346-59.
52. Aapro MS, Link H,. September 2007 update on EORTC guidelines and anemia management with erythropoiesis stimulating agents. Oncologist 2008; 13: 33-6.
53. Lichtin AE,. Clinical practice guidelines for the use of erythroid-stimulating agents: ASCO, EORTC, NCCN. Cancer Treatment and Research 2011; 157: 239-48.
54. Stowell CP, Jones SC, Enny C, Langholff W, Leitz G,. An open-label, randomized, parallel-group study of perioperative epoetin alfa versus standard of care for blood conservation in major elective spinal surgery: safety analysis. Spine 2009; 34: 2479-85.
55. Kaplan E, Sheiner L, Boeckmann A, et al., The usefulness of preoperative laboratory screening. Journal of the American Medical Association 1985; 253: 3576-81.
56. Dzik WH,. Predicting hemorrhage using preoperative coagulation screening assays. Current Hematology Reports 2004; 3: 324-30.
57. Velanovich V,. The value of routine preoperative laboratory testing in predicting postoperative complications: a multivariate analysis. Surgery 1991; 109: 236-43.
58. Macpherson CR, Jacobs P, Dent DM,. Abnormal peri-operative haemorrhage in asymptomatic patients is not predicted by laboratory testing. South Africa Medical Journal 1993; 83: 106-8.
59. Koscielny J, von Tempelhoff GF, Ziemer S, et al., A practical concept for preoperative management of patients with impaired primary hemostasis. Clinical and Applied Thrombosis/Hemostasis 2004; 10: 155-66.
60. Pfanner G, Koscielny J, Pernerstorfer T, et al., [ Preoperative evaluation of the bleeding history. Recommendations of the working group on perioperative coagulation of the Austrian Society for Anaesthesia, Resuscitation and Intensive Care ]. Anaesthesist 2007; 56: 604-11.
61. OEGARI. http://www.oegari.at/web-files/dateiarchiv/editor/quellleitlinie-praeoperative-patientinnenevaluierung-gueltigkeit-aufrecht-2.pdf (accessed 24/07/2015).
62. Ciavarella D, Reed R, Counts R, et al., Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. British Journal of Haematology 1987; 67: 365-8.
63. Rahe-Meyer N, Solomon C, Winterhalter M, et al., Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. Journal of Thoracic and Cardiovascular Surgery 2009; 138: 694-702.
64. Charbit B, Mandelbrot L, Samain E, et al., The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. Journal of Thrombosis and Haemostasis 2007; 5: 266-73.
65. Counts RB, Haisch C, Simon TL, Maxwell NG, Heimbach DM, Carrico CJ,. Hemostasis in massively transfused trauma patients. Annals of Surgery 1979; 190: 91-9.
66. de Lloyd L, Bovington R, Kaye A, et al., Standard haemostatic tests following major obstetric haemorrhage. International Journal of Obstetric Anesthesia 2011; 20: 135-41.
67. Yuan S, Ferrell C, Chandler WL,. Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma. Thrombosis Research 2007; 120: 29-37.
68. MacLeod JB, Lynn M, McKenney MG, Cohn SM, Murtha M,. Early coagulopathy predicts mortality in trauma. Journal of Trauma 2003; 55: 39-44.
69. Merritt JC, Bhatt DL,. The efficacy and safety of perioperative antiplatelet therapy. Journal of Thrombosis and Thrombolysis 2004; 17: 21-7.
70. Tanaka KA, Szlam F, Kelly AB, Vega JD, Levy JH,. Clopidogrel (Plavix) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding. Platelets 2004; 15: 325-32.
71. Siller-Matula JM, Petre A, Delle-Karth G, et al., Impact of preoperative use of P2Y12 receptor inhibitors on clinical outcomes in cardiac and non-cardiac surgery: a systematic review and meta-analysis. European Heart Journal. Acute Cardiovascular Care 2015; doi: 10.1177/2048872615585516
72. Lillicrap D, Nair SC, Srivastava A, Rodeghiero F, Pabinger I, Federici AB,. Laboratory issues in bleeding disorders. Haemophilia 2006; 12: 68-75.
73. Rodgers RP,. Bleeding time tables: a tabular summary of pertinent literature. Seminars in Thrombosis and Hemostasis 1990; 16: 21-38.
74. Mannucci PM, Federici AB, Sirchia G,. Hemostasis testing during massive blood replacement. A study of 172 cases. Vox Sanguinis 1982; 42: 113-23.
75. Escolar G, Cases A, Vinas M, et al., Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100): influence of hematocrit elevation. Haematologica 1999; 84: 614-9.
76. Barrowcliffe TW, Cattaneo M, Podda GM, et al., New approaches for measuring coagulation. Haemophilia 2006; 12: 76-81.
77. Wahba A, Sander S, Birnbaum DE,. Are in-vitro platelet function tests useful in predicting blood loss following open heart surgery? Thoracic and Cardiovascular Surgeon 1998; 46: 228-31.
78. Forestier F, Coiffic A, Mouton C, Ekouevi D, Chene G, Janvier G,. Platelet function point-of-care tests in post-bypass cardiac surgery: are they relevant? British Journal of Anaesthesia 2002; 89: 715-21.
79. Paniccia R, Antonucci E, Maggini N, et al., Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy. American Journal of Clinical Pathology 2009; 131: 834-42.
80. Sibbing D, Braun S, Jawansky S, et al., Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thrombosis and Haemostasis 2008; 99: 121-6.
81. Jambor C, Weber C, Gerhardt K, et al., Whole blood multiple electrode aggregometry is a reliable point-of-care test of aspirin-induced platelet dysfunction. Anesthesia and Analgesia 2009; 109: 25-31.
82. Velik-Salchner C, Maier S, Innerhofer P, et al., An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study. Anesthesia and Analgesia 2009; 108: 1747-54.
83. Shore-Lesserson L,. Evidence based coagulation monitors: heparin monitoring, thromboelastography, and platelet function. Seminars in Cardiothoracic and Vascular Anesthesia 2005; 9: 41-52.
84. Kozek-Langenecker S,. Global and European bleeding management guidelines. http://www.peri-operativebleeding.org (accessed 24/07/2015).
85. Mahla E, Suarez TA, Bliden KP, et al., Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. Circulation. Cardiovascular Interventions 2012; 5: 261-9.